MarkeTrak 2025: Hearing Aids in the Age of OTCs and Wearables
HIA's MarkeTrak 2025 study of the U.S. hearing loss market provides new data on prescription hearing aids, OTC devices, and emerging technologies.
HIA's MarkeTrak 2025 study of the U.S. hearing loss market provides new data on prescription hearing aids, OTC devices, and emerging technologies.
A review of the rationale for and enhanced features in AutoSense OS 3.0 with binaural signal processing, and how the new system is designed to achieve the most appropriate settings for the wearer, optimizing hearing performance in all listening environments, including media streaming.
MarkeTrak data suggest that verification and validation procedures can reduce unnecessary refitting appointments by up to 521,000 visits on an annual industry-wide basis—or about 390,000 hours in time saved for patients and dispensing professionals. This represents a tremendous amount of time that could be more efficiently spent on other facets of patient care, business management, and new patient acquisition.
Consumer satisfaction ratings of completely-in-the-canal (CIC) hearing aids are equal or favorable to the most current [1994] MarkeTrak profile. CICs received better scores in key areas such as visibility, directionality, feedback, and performance while on the phone and in outdoor situations. Statistics point to CICs attracting a more youthful, less hearing-impaired market. CICs provide benefit, as measured by the APHAB, equivalent to the typical new hearing instrument.
Read More